Journal of Interventional Cardiology

Research Article

Rotablation in Patients with Advanced Renal Insufficiency through End-Stage Renal Disease: Short- and Intermediate-Term Results

Table 4

Clinical outcomes of rotational atherectomy in patients with CR < 5 mg/d and CR ≥ 5 mg/dl through ESRD.


Variables	Group A	Group B	value
	(CR < 5 mg/dl)	(CR ≥ 5 mg/dl through ESRD)
	N = 338	N = 73

In-hospital
MACE (N, %)	21 (6.2%)	10 (13.7%)	0.028
CV MACE (N, %)	17 (5.0%)	5 (6.8%)	0.531
Death (N, %)	18 (5.3%)	9 (12.3%)	0.029
CV death (N, %)	13 (3.8%)	4 (5.5%)	0.525
Fatal MI (N, %)	1 (0.3%)	1 (1.4%)	0.232
Nonfatal MI (N, %)	3 (0.9%)	0	0.419
Stent thrombosis (N, %)	1 (0.3%)	0	0.642
Stroke (N, %)	1 (0.3%)	0	0.642
TLR (N, %)	0	0	N/A
TVR (N, %)	2 (0.6%)	1 (1.4%)	0.479
30-day
MACE (N, %)	30 (8.9%)	11 (15.1%)	0.111
CV MACE (N, %)	23 (6.8%)	7 (9.6%)	0.411
Death (N, %)	24 (7.1%)	9 (12.3%)	0.138
CV death (N, %)	16 (4.7%)	5 (6.8%)	0.460
Fatal MI (N, %)	1 (0.3%)	1 (1.4%)	0.233
Nonfatal MI (N, %)	3 (0.9%)	0	0.418
Stent thrombosis (N, %)	3 (0.9%)	0	0.418
Stroke (N, %)	2 (0.6%)	0	0.509
TLR (N, %)	2 (0.6%)	1 (1.4%)	0.480
TVR (N, %)	4 (1.2%)	2 (2.7%)	0.317
90-day
MACE (N, %)	47 (13.9%)	16 (21.9%)	0.089
CV MACE (N, %)	34 (10.1%)	11 (15.1%)	0.221
Death (N, %)	32 (9.5%)	10 (13.7%)	0.287
CV death (N, %)	18 (5.3%)	5 (6.8%)	0.616
Fatal MI (N, %)	1 (0.3%)	1 (1.4%)	0.234
Nonfatal MI (N, %)	5 (1.5%)	1 (1.4%)	0.939
Stent thrombosis (N, %)	3 (0.9%)	0	0.418
Stroke (N, %)	2 (0.6%)	0	0.509
TLR (N, %)	9 (2.7%)	4 (5.5%)	0.216
TVR (N, %)	12 (3.6%)	6 (8.2%)	0.079
180-day
MACE (N, %)	73 (21.6%)	27 (37.0%)	0.006
CV MACE (N, %)	54 (16.0%)	21 (28.8%)	0.011
Death (N, %)	47 (13.9%)	12 (16.4%)	0.589
CV death (N, %)	25 (7.4%)	5 (6.8%)	0.861
Fatal MI (N, %)	2 (0.6%)	2 (2.7%)	0.091
Nonfatal MI (N, %)	8 (2.4%)	2 (2.7%)	0.857
Stent thrombosis (N, %)	3 (0.9%)	0	0.418
Stroke (N, %)	3 (0.9%)	0	0.418
TLR (N, %)	21 (6.2%)	13 (17.8%)	0.001
TVR (N, %)	26 (7.7%)	15 (20.5%)	0.001
1-year
MACE (N, %)	96 (28.4%)	35 (47.9%)	0.001
CV MACE (N, %)	65 (19.2%)	27 (37.0%)	0.001
Death (N, %)	65 (19.2%)	18 (24.7%)	0.306
CV death (N, %)	26 (7.7%)	7 (9.6%)	0.599
Fatal MI (N, %)	4 (1.2%)	4 (5.5%)	0.016
Nonfatal MI (N, %)	10 (3.0%)	3 (4.1%)	0.617
Stent thrombosis (N, %)	4 (1.2%)	0	0.349
Stroke (N, %)	3 (0.9%)	1 (1.4%)	0.707
TLR (N, %)	31 (9.2%)	17 (23.3%)	0.001
TVR (N, %)	37 (10.9%)	20 (27.4%)	<0.001

CR, creatinine; CV, cardiovascular; ESRD, end-stage renal disease; MACE, major adverse cardiovascular event; MI, myocardial infarction; TLR, target lesion revascularization; TVR, target vessel revascularization.